BCL2A1 and hepatocellular adenoma: A limitation of this study is that we have not yet conducted research on BCL2A1 gene-related markers (i.e., cell-free fetal [cff] DNA and cff-RNA) in maternal plasma for predicting acute HCA characterized by BCL2A1 expression in the EPM.